ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $45M invested in ADMA Biologics in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $48M → $45M (-$2.95M)
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$93K | |
| 2 | +$52K | |
| 3 | +$26.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.6K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$13.2K |
Top Sellers
| 1 | -$413K | |
| 2 | -$293K | |
| 3 | -$114K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$99 |